Literature DB >> 17460772

Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction.

Svetlana A Tsareva1, Richard Moriggl, Florian M Corvinus, Bernd Wiederanders, Alexander Schütz, Boris Kovacic, Karlheinz Friedrich.   

Abstract

Signal transducer and activator of transcription 3 (STAT3) is aberrantly activated in colorectal carcinomas (CRCs). Here, we define the relationship between STAT3 function and the malignant properties of colon carcinoma cells. Elevated activation of STAT3 enhances invasive growth of the CRC cell lines. To address mechanisms through which STAT3 influences invasiveness, the protease mRNA expression pattern of CRC biopsies was analyzed and correlated with the STAT3 activity status. These studies revealed a striking coincidence of STAT3 activation and strong expression of matrix metalloproteinases MMP-1, -3, -7, and -9. Immunohistological examination of CRC tumor specimens showed a clear colocalization of MMP-1 and activated STAT3. Experimentally induced STAT3 activity in CRC cell lines enhanced both the level of MMP-1 mRNA and secreted MMP-1 enzymatic activity. A direct connection of STAT3 activity and transcription from the MMP-1 promoter was shown by reporter gene experiments. Moreover, high-affinity binding of STAT3 to STAT recognition elements in both the MMP-1 and MMP-3 promoter was demonstrated. Xenograft tumors arising from implantation of CRC cells into nude mice showed simultaneous appearance and colocalization of p-Y-STAT3 and MMP-1 expression. Our results link aberrant activity of STAT3 in CRC to malignant tumor progression through upregulated expression of MMPs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460772      PMCID: PMC1854849          DOI: 10.1593/neo.06820

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  70 in total

Review 1.  Matrix metalloproteinases in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

2.  Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

Authors:  G Niu; R Heller; R Catlett-Falcone; D Coppola; M Jaroszeski; W Dalton; R Jove; H Yu
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

Review 3.  Matrix metalloproteinases in human melanoma.

Authors:  U B Hofmann; J R Westphal; G N Van Muijen; D J Ruiter
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

4.  Ets domain transcription factor PE1 suppresses human interstitial collagenase promoter activity by antagonizing protein-DNA interactions at a critical AP1 element.

Authors:  M Bidder; A P Loewy; T Latifi; E P Newberry; G Ferguson; D M Willis; D A Towler
Journal:  Biochemistry       Date:  2000-08-01       Impact factor: 3.162

5.  Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.

Authors:  Akio Horiguchi; Mototsugu Oya; Tetsuya Shimada; Atsushi Uchida; Ken Marumo; Masaru Murai
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

6.  Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B.

Authors:  Pierre Olivier Estève; Eric Chicoine; Olivier Robledo; Fawzi Aoudjit; Albert Descoteaux; Edouard F Potworowski; Yves St-Pierre
Journal:  J Biol Chem       Date:  2002-07-18       Impact factor: 5.157

7.  Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.

Authors:  Beatrix Vécsey-Semjén; Karl-Friedrich Becker; Alexandra Sinski; Elizabeth Blennow; Ilja Vietor; Kurt Zatloukal; Hartmut Beug; Ernst Wagner; Lukas A Huber
Journal:  Oncogene       Date:  2002-07-11       Impact factor: 9.867

8.  The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1.

Authors:  Marie-Claire Hall; David A Young; Jasmine G Waters; Andrew D Rowan; Andrew Chantry; Dylan R Edwards; Ian M Clark
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

9.  Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung.

Authors:  A Schütz; D Schneidenbach; G Aust; A Tannapfel; M Steinert; C Wittekind
Journal:  Tumour Biol       Date:  2002 May-Jun

10.  STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene.

Authors:  Lorena Lerner; Melissa A Henriksen; Xiaokui Zhang; James E Darnell
Journal:  Genes Dev       Date:  2003-10-01       Impact factor: 11.361

View more
  60 in total

Review 1.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

2.  Development of analytical methods for multiplex bio-assay with inductively coupled plasma mass spectrometry.

Authors:  Olga I Ornatsky; Robert Kinach; Dmitry R Bandura; Xudong Lou; Scott D Tanner; Vladimir I Baranov; Mark Nitz; Mitchell A Winnik
Journal:  J Anal At Spectrom       Date:  2008       Impact factor: 4.023

3.  Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1.

Authors:  Hao H Ho; Taras T Antoniv; Jong-Dae Ji; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma.

Authors:  Kate E Keller; Yong-Feng Yang; Ying Ying Sun; Renee Sykes; Natalie Donna Gaudette; John R Samples; Ted S Acott; Mary K Wirtz
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-23       Impact factor: 2.671

5.  Novel Proteome Extraction Method Illustrates a Conserved Immunological Signature of MSI-H Colorectal Tumors.

Authors:  Elez D Vainer; Juliane Kania-Almog; Ghadeer Zatara; Yishai Levin; Gilad W Vainer
Journal:  Mol Cell Proteomics       Date:  2020-07-08       Impact factor: 5.911

6.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

7.  Release of liposomal contents by cell-secreted matrix metalloproteinase-9.

Authors:  Jayati Banerjee; Andrea J Hanson; Bhushan Gadam; Adekunle I Elegbede; Shakila Tobwala; Bratati Ganguly; Anil V Wagh; Wallace W Muhonen; Benedict Law; John B Shabb; D K Srivastava; Sanku Mallik
Journal:  Bioconjug Chem       Date:  2009-07       Impact factor: 4.774

8.  Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer.

Authors:  Aditi Hazra; Charles S Fuchs; Takako Kawasaki; Gregory J Kirkner; David J Hunter; Shuji Ogino
Journal:  Cancer Causes Control       Date:  2010-03       Impact factor: 2.506

9.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

10.  Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.

Authors:  Lian-Zhen Yu; Hai-Yang Wang; Shu-Ping Yang; Zhi-Ping Yuan; Fang-Yuan Xu; Chao Sun; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.